The DOI matches its Crossref record.
Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cells
Open accessAbstract
Adenosine has potent effects on both the cardiovascular and immune systems. Exposure of tissues to adenosine results in increased vascular permeability and extravasation of serum proteins. The mechanism by which adenosine brings about these physiological changes is poorly defined. Using mice deficient in the A(3) adenosine receptor (A(3)AR), we show that increases in cutaneous vascular permeability observed after treatment with adenosine or its principal metabolite inosine are mediated through the A(3)AR. Adenosine fails to increase vascular permeability in mast cell-deficient mice, suggesting that this tissue response to adenosine is mast cell-dependent. Furthermore, this response is independent of activation of the high-affinity IgE receptor (FcepsilonR1) by antigen, as adenosine is equally effective in mediating these changes in FcepsilonR1 beta-chain-deficient mice. Together these results support a model in which adenosine and inosine induce changes in vascular permeability indirectly by activating mast cells, which in turn release vasoactive substances. The demonstration in vivo that adenosine, acting through a specific receptor, can provoke degranulation of this important tissue-based effector cell, independent of antigen activation of the high-affinity IgE receptor, supports an important role for this nucleoside in modifying the inflammatory response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances
Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. M., & Tsai, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141025 · Cited by 1,017
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Role of Arthropod Saliva in Blood Feeding: Sialome and Post-Sialome Perspectives
Ribeiro, J. M. C., & Francischetti, I. M. B. (2003) · Annual Review of Entomology · doi:10.1146/annurev.ento.48.060402.102812 · Cited by 743
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
Linden, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.775 · Cited by 685
Essential role for the p110δ phosphoinositide 3-kinase in the allergic response
Ali, K., Bilancio, A., Thomas, M., Pearce, W., Gilfillan, A. M., Tkaczyk, C., Kuehn, N., Gray, A., Giddings, J., Peskett, E., et al. (2004) · Nature · doi:10.1038/nature02991 · Cited by 387
ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and Drugs
Fredholm, B. B., Chen, J.-F., Masino, S. A., & Vaugeois, J.-M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095731 · Cited by 354
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
Yang, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27933 · Cited by 349
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
Purinergic signalling and immune cells
Burnstock, G., & Boeynaems, J.-M. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9427-2 · Cited by 309
Immunomodulatory and neuroprotective effects of inosine
Haskó, G., Sitkovsky, M. V., & Szabó, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.006 · Cited by 308
Ophidian envenomation strategies and the role of purines
Aird, S. D. (2002) · Toxicon · doi:10.1016/s0041-0101(01)00232-x · Cited by 300
Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function
Laffargue, M., Calvez, R., Finan, P., Trifilieff, A., Barbier, M., Altruda, F., Hirsch, E., & Wymann, M. P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00282-0 · Cited by 286
Signaling and regulation of G protein-coupled receptors in airway smooth muscle
Billington, C. K., & Penn, R. B. (2003) · Respiratory Research · doi:10.1186/1465-9921-4-2 · Cited by 284
Anaphylaxis: Mechanisms of Mast Cell Activation
Kalesnikoff, J., & Galli, S. J. (2010) · Chemical Immunology and Allergy · doi:10.1159/000315937 · Cited by 67
Metadata
- Authors
- Tilley, S. L., Wagoner, V. A., Salvatore, C. A., Jacobson, M. A., & Koller, B. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 361-367
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2053225881
- Cited by
- 181
- References
- 0
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.